Challenges in Colorectal Cancer and over 450,000 other books are available for Amazon Kindle – Amazon’s new wireless reading device. Learn more

 

or
Sign in to turn on 1-Click ordering.
 
 
Express Checkout with PayPhrase
What's this? | Create PayPhrase
More Buying Choices
29 used & new from $37.58

Have one to sell? Sell yours here
 
   
Challenges in Colorectal Cancer
 
 
Start reading Challenges in Colorectal Cancer on your Kindle in under a minute.

Don’t have a Kindle? Get your Kindle here.
 
  

Challenges in Colorectal Cancer (Hardcover)

~ John Scholefield (Editor), Herand Abcarian (Editor), Tim Maughan (Editor), Axel Grothey (Editor) "Can lifestyle cause colorectal cancer (CRC)?..." (more)
Key Phrases: Clin Oncol, Ann Surg, Dis Colon Rectum (more...)
No customer reviews yet. Be the first.

Price: $157.95 & this item ships for FREE with Super Saver Shipping. Details
o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o o
In Stock.
Ships from and sold by Amazon.com. Gift-wrap available.

Only 1 left in stock--order soon (more on the way).

Want it delivered Friday, March 19? Choose One-Day Shipping at checkout. Details
17 new from $117.72 12 used from $37.58

Formats

Amazon Price New from Used from
Kindle Edition $119.96  
Hardcover $157.95  

Frequently Bought Together

Customers buy this book with Complications in Surgery by Michael W Mulholland

Challenges in Colorectal Cancer + Complications in Surgery
Price For Both: $301.15

Show availability and shipping details

  • This item: Challenges in Colorectal Cancer by John Scholefield

    In Stock.
    Ships from and sold by Amazon.com.
    This item ships for FREE with Super Saver Shipping. Details

  • Complications in Surgery by Michael W Mulholland

    In Stock.
    Ships from and sold by Amazon.com.
    This item ships for FREE with Super Saver Shipping. Details


Editorial Reviews

From The New England Journal of Medicine

Colorectal cancer presents some of the most challenging problems for basic scientists, clinical investigators, and practitioners. It will be important to facilitate an ongoing exchange among these three groups if we are to transform many small steps into a major advance in the treatment of colorectal cancer. Surgery remains the center of attention, for two reasons. First, in any high-risk case, the surgeon must coordinate the various treatment options (e.g., preoperative, intraoperative, and postoperative adjuvant treatment); second, the surgeon determines the prognosis, since inadequate surgical technique can influence a patient's outcome more than can the stage of the disease. But there are new trends, such as risk-adjusted screening, brought about by molecular techniques that have deepened our understanding of the pathogenesis of colorectal cancer. The demonstration of micrometastases in stage II and III cancers has sharpened the need for effective adjuvant therapy.

This book deals with these challenges and presents important new developments. A consensus has evolved with respect to diagnostic and therapeutic strategies in dominantly inherited colorectal cancers (familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer); by contrast, the rules for the early diagnosis of and screening for sporadic cancer remain undefined. Screening of the general population is effective but costly.

It is increasingly evident that preoperative chemotherapy or the combination of radiation therapy and chemotherapy can improve results in the treatment of rectal cancer. Experience during the past 15 years has clearly demonstrated the value of chemotherapy in high-risk colorectal cancer. It will become necessary to change the usual postoperative treatment with radiation or a combination of radiation therapy and chemotherapy to a preoperative combination, perhaps with additional intraoperative irradiation followed by postoperative chemotherapy. It is still debatable whether the excellent results of total mesorectal excision in patients with rectal cancer eliminates the need for preoperative, intraoperative, or postoperative radiation therapy. Tumor that has spread to the lymph nodes along the mesenteric border can easily be removed surgically, but removal of tumor that has spread to the pelvic wall is not part of the standard surgical procedure. Extended surgical procedures lead to high rates of irreversible loss of bladder control and impaired sexual function.

A number of new chemotherapeutic agents (oxaliplatin, irinotecan, and topotecan) and several types of immunotherapy are promising and may have clinical applications, but only if minimal residual disease can be diagnosed reliably. Dormant tumor cells are a reality and can be treated with the monoclonal antibody 17-1A. In the end, however, the solution will probably be a combination of immunotherapy and chemotherapy.

More knowledge of molecular biology, better definition of risk groups, better screening, further development of risk-oriented combination therapy, and more meticulous surgery may yield much higher cure rates for colon and rectal cancer. Scholefield's book is one of the best starting points for a journey through the world of established, new, and evolving treatments for these diseases.

Christian Herfarth, M.D.
Copyright © 2000 Massachusetts Medical Society. All rights reserved. The New England Journal of Medicine is a registered trademark of the MMS. --This text refers to an out of print or unavailable edition of this title.

Review

"The text is extremely well references and well illustrated and provides a worthwhile edition to the library of all workers in the field."
Colorectal Disease, 2007

"A good book looking at the total management of patients with this condition and aimed at the entire medical team caring fro those with colorectal cancer."
Digestive and Liver Disease, 2007

From a review of the first edition:
“More knowledge of molecular biology, better definition of risk groups, better screening, further development of risk- oriented combination therapy, and more meticulous surgery may yield much higher cure rates for colon and rectal cancer. Scholefield’s book is one of the best starting points for a journey through the world of established, new, and evolving treatments for these diseases.”
New England Journal of Medicine, September 2000


Product Details


Inside This Book (learn more)

Citations (learn more)
This book cites 21 books:
See all 21 books this book cites
 
1 book cites this book:



What Do Customers Ultimately Buy After Viewing This Item?

Challenges in Colorectal Cancer
86% buy the item featured on this page:
Challenges in Colorectal Cancer
$157.95
Be a Survivor: Colorectal Cancer Treatment Guide
14% buy
Be a Survivor: Colorectal Cancer Treatment Guide 5.0 out of 5 stars (3)
$18.21

Tag this product

 (What's this?)
Think of a tag as a keyword or label you consider is strongly related to this product.
Tags will help all customers organize and find favorite items.
Your tags: Add your first tag
 

Customer Reviews


There are no customer reviews yet.
Video reviews
Video reviews
Amazon now allows customers to upload product video reviews. Use a webcam or video camera to record and upload reviews to Amazon.



Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   


Listmania!


Create a Listmania! list

So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject

 

Feedback

If you need help or have a question for Customer Service, contact us.
 Would you like to update product info or give feedback on images?
Is there any other feedback you would like to provide?

Your comments can help make our site better for everyone.


Your Recent History

 (What's this?)

After viewing product detail pages or search results, look here to find an easy way to navigate back to pages you are interested in.